Loading...

CNTB CONNECT BIOPHARMA HOLDINGS LTD Expansion Plans 8-K Filing

CNNC

CNTB

CONNECT BIOPHARMA HOLDINGS LTD

(CNTB)

2025 8-K

Financial Results Released

Share Placement Funding

Board Resignation

Financial Results Announced

Insider Share Purchases

Financial Results Released

Equity Offerings

New Drug Application

Financial Statements

Market Expansion

Product Expansion

FDA Meeting Update

Financial Results

Nasdaq Compliance Notice

Management Changes

Management Changes

Financial Results Update

Management Changes

Management Changes

Financial Results Announcement

Board Appointment

External Links:

On May 14, 2025, Connect Biopharma Holdings Ltd announced the start of its Phase 2 Seabreeze study for treating chronic obstructive pulmonary disease, having received FDA approval on the study protocol. The company plans to release topline data in the first half of 2026.

AI Assistant

CONNECT BIOPHARMA HOLDINGS LTD

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.